Comparison

TGX221 European Partner

Manufacturer TargetMol
Category
Type Molecules
Specific against other
Amount 50mg
Item no. TMO-T2661-50mg
Targets PI3K
CASRN 663619-89-4
eClass 6.1 32169090
eClass 9.0 32169090
Available
Short Description
TGX-221, an effective, specific, and cell membrane permeable inhibitor of the PI3K p110β catalytic subunit, is utilized for cancer treatment.
Shipping
cool pack
Storage
-20°
Target names or alias
TGX221
Molecular Weight
364, 44
Pathway
PI3K/Akt/mTOR signaling
Target
PI3K

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50mg
Available: In stock
available

Delivery expected until 6/6/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close